104 related articles for article (PubMed ID: 8757016)
1. Predictors of mortality in patients diagnosed with probable Alzheimer's disease.
Bowen JD; Malter AD; Sheppard L; Kukull WA; McCormick WC; Teri L; Larson EB
Neurology; 1996 Aug; 47(2):433-9. PubMed ID: 8757016
[TBL] [Abstract][Full Text] [Related]
2. Mortality and temporal course of probable Alzheimer's disease: a 5-year prospective study.
Reisberg B; Ferris SH; Franssen EH; Shulman E; Monteiro I; Sclan SG; Steinberg G; Kluger A; Torossian C; de Leon MJ; Laska E
Int Psychogeriatr; 1996; 8(2):291-311. PubMed ID: 8994898
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of possible versus probable Alzheimer's disease.
Villareal DT; Grant E; Miller JP; Storandt M; McKeel DW; Morris JC
Neurology; 2003 Sep; 61(5):661-7. PubMed ID: 12963758
[TBL] [Abstract][Full Text] [Related]
4. Survival after initial diagnosis of Alzheimer disease.
Larson EB; Shadlen MF; Wang L; McCormick WC; Bowen JD; Teri L; Kukull WA
Ann Intern Med; 2004 Apr; 140(7):501-9. PubMed ID: 15068977
[TBL] [Abstract][Full Text] [Related]
5. Extrapyramidal signs in patients with probable Alzheimer disease.
Lopez OL; Wisnieski SR; Becker JT; Boller F; DeKosky ST
Arch Neurol; 1997 Aug; 54(8):969-75. PubMed ID: 9267971
[TBL] [Abstract][Full Text] [Related]
6. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease.
Olichney JM; Galasko D; Salmon DP; Hofstetter CR; Hansen LA; Katzman R; Thal LJ
Neurology; 1998 Aug; 51(2):351-7. PubMed ID: 9710002
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of mortality in Alzheimer's disease patients with higher education? A replication study.
Geerlings MI; Deeg DJ; Schmand B; Lindeboom J; Jonker C
Neurology; 1997 Sep; 49(3):798-802. PubMed ID: 9305343
[TBL] [Abstract][Full Text] [Related]
8. Mortality in Alzheimer's disease: a comparative prospective Korean study in the community and nursing homes.
Suh GH; Kil Yeon B; Shah A; Lee JY
Int J Geriatr Psychiatry; 2005 Jan; 20(1):26-34. PubMed ID: 15578675
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication.
Yang YH; Wu MN; Chou PS; Su HC; Lin SH; Sung PS
Curr Alzheimer Res; 2018 Mar; 15(5):474-481. PubMed ID: 29032750
[TBL] [Abstract][Full Text] [Related]
10. The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease.
Morris JC; Edland S; Clark C; Galasko D; Koss E; Mohs R; van Belle G; Fillenbaum G; Heyman A
Neurology; 1993 Dec; 43(12):2457-65. PubMed ID: 8255439
[TBL] [Abstract][Full Text] [Related]
11. Mini-Mental State Examination item scores as predictors of Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm.
Small BJ; Viitanen M; Bäckman L
J Gerontol A Biol Sci Med Sci; 1997 Sep; 52(5):M299-304. PubMed ID: 9310084
[TBL] [Abstract][Full Text] [Related]
12. The consortium to establish a registry for Alzheimer's disease (CERAD). Part XIV: Demographic and clinical predictors of survival in patients with Alzheimer's disease.
Heyman A; Peterson B; Fillenbaum G; Pieper C
Neurology; 1996 Mar; 46(3):656-60. PubMed ID: 8618662
[TBL] [Abstract][Full Text] [Related]
13. Mortality risk after dementia diagnosis by dementia type and underlying factors: a cohort of 15,209 patients based on the Swedish Dementia Registry.
Garcia-Ptacek S; Farahmand B; Kåreholt I; Religa D; Cuadrado ML; Eriksdotter M
J Alzheimers Dis; 2014; 41(2):467-77. PubMed ID: 24625796
[TBL] [Abstract][Full Text] [Related]
14. Natural progression model of cognition and physical functioning among people with mild cognitive impairment and alzheimer's disease.
Handels RL; Xu W; Rizzuto D; Caracciolo B; Wang R; Winblad B; Verhey FR; Severens JL; Fratiglioni L; Joore MA; Wimo A
J Alzheimers Dis; 2013; 37(2):357-65. PubMed ID: 23948894
[TBL] [Abstract][Full Text] [Related]
15. Neurological and psychiatric predictors of mortality in patients with Alzheimer disease in California.
Moritz DJ; Fox PJ; Luscombe FA; Kraemer HC
Arch Neurol; 1997 Jul; 54(7):878-85. PubMed ID: 9236577
[TBL] [Abstract][Full Text] [Related]
16. Gender differences in the relation between comorbidity and mortality of patients with Alzheimer's disease. Systematic Assessment of Geriatric drug use via Epidemiology (SAGE) Study Group.
Gambassi G; Lapane KL; Landi F; Sgadari A; Mor V; Bernabie R
Neurology; 1999 Aug; 53(3):508-16. PubMed ID: 10449112
[TBL] [Abstract][Full Text] [Related]
17. Predictors of mortality in patients with Alzheimer's disease living in nursing homes.
Gambassi G; Landi F; Lapane KL; Sgadari A; Mor V; Bernabei R
J Neurol Neurosurg Psychiatry; 1999 Jul; 67(1):59-65. PubMed ID: 10369823
[TBL] [Abstract][Full Text] [Related]
18. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.
Kahle-Wrobleski K; Andrews JS; Belger M; Ye W; Gauthier S; Rentz DM; Galasko D
J Prev Alzheimers Dis; 2017; 4(2):72-80. PubMed ID: 29186278
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease.
Bruandet A; Richard F; Bombois S; Maurage CA; Deramecourt V; Lebert F; Amouyel P; Pasquier F
J Neurol Neurosurg Psychiatry; 2009 Feb; 80(2):133-9. PubMed ID: 18977819
[TBL] [Abstract][Full Text] [Related]
20. EEG spectral abnormalities and psychosis as predictors of cognitive and functional decline in probable Alzheimer's disease.
Lopez OL; Brenner RP; Becker JT; Ulrich RF; Boller F; DeKosky ST
Neurology; 1997 Jun; 48(6):1521-5. PubMed ID: 9191759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
